Judge: Defendants’ Alleged Misrepresentations Not Actionable In Securities Suit
NEWARK, N.J. — Lead plaintiffs in a securities class action lawsuit against a pharmaceutical company and its CEO have failed to plead any material misstatements or omissions in arguing that the...To view the full article, register now.
Already a subscriber? Click here to view full article